Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Mayfield, Karla, Dan Siskind, Karl Winckel, Anthony W. Russell, Steve Kisely, Greg Smith, and Samantha Hollingworth. "Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes." Journal of Psychopharmacology 30, no. 3 (2016): 227-236. |
|
Fond, Guillaume, Christophe Lançon, Pascal Auquier, and Laurent Boyer. "C-Reactive protein as a peripheral biomarker in schizophrenia. An updated systematic review." Frontiers in psychiatry 9 (2018): 392. |
|
Blum, Kenneth, Thomas JH Chen, John Bailey, Abdalla Bowirrat, John Femino, Amanda LC Chen, Thomas Simpatico et al. "Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?." Molecular neurobiology 44, no. 3 (2011): 250-268. |
|
Chwastiak, Lydia A., Oliver Freudenreich, Cenk Tek, Christine McKibbin, Jaesu Han, Robert McCarron, and Brent Wisse. "Clinical management of comorbid diabetes and psychotic disorders." The Lancet Psychiatry 2, no. 5 (2015): 465-476. |
|
Darville, Nicolas, Jukka Saarinen, Antti Isomäki, Leonid Khriachtchev, Dirk Cleeren, Patrick Sterkens, Marjolein Van Heerden et al. "Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions." European Journal of Pharmaceutics and Biopharmaceutics 96 (2015): 338-348. |
|
Mulligan, Kathleen, Hayley McBain, Frederique Lamontagne?Godwin, Jacqui Chapman, Mark Haddad, Julia Jones, Chris Flood, David Thomas, and Alan Simpson. "Barriers and enablers of type 2 diabetes self?management in people with severe mental illness." Health expectations 20, no. 5 (2017): 1020-1030. |
|
Rosenquist, Peter B., Brian Miller, and Anilkumar Pillai. "The antipsychotic effects of ECT: a review of possible mechanisms." The journal of ECT 30, no. 2 (2014): 125-131. |
|
Holt, Richard IG, and Alex J. Mitchell. "Diabetes mellitus and severe mental illness: mechanisms and clinical implications." Nature Reviews Endocrinology 11, no. 2 (2015): 79-89. |
|
Hwang, Rudi, Arun K. Tiwari, Clement C. Zai, Daniel Felsky, Eli Remington, Tessa Wallace, Ryan P. Tong et al. "Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration." Progress in Neuro-Psychopharmacology and Biological Psychiatry 37, no. 1 (2012): 62-75. |
|
Mohammadi, Alireza, Ehsan Rashidi, and Vahid Ghasem Amooeian. "Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia." Psychiatry research 265 (2018): 25-38. |
|
Chue, Pierre, and James Chue. "A review of aripiprazole long-acting injection." Current medical research and opinion 32, no. 3 (2016): 441-452. |
|
Hardaway, J. Andrew, Shannon L. Hardie, Sarah M. Whitaker, Sarah R. Baas, Bing Zhang, Daniel P. Bermingham, Ariana J. Lichtenstein, and Randy D. Blakely. "Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis." G3: Genes| Genomes| Genetics 2, no. 8 (2012): 961-975. |
|
Inoshita, Masatoshi, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Hidehiro Umehara, Masahito Nakataki, Masashi Ikeda et al. "A significant causal association between C-reactive protein levels and schizophrenia." Scientific reports 6, no. 1 (2016): 1-8. |
|
Darville, Nicolas, Marjolein Van Heerden, Tim Erkens, Sandra De Jonghe, An Vynckier, Marc De Meulder, An Vermeulen, Patrick Sterkens, Pieter Annaert, and Guy Van den Mooter. "Modeling the time course of the tissue responses to intramuscular long-acting paliperidone palmitate nano-/microcrystals and polystyrene microspheres in the rat." Toxicologic pathology 44, no. 2 (2016): 189-210. |
|
Rolls, Edmund T. "Glutamate, obsessive–compulsive disorder, schizophrenia, and the stability of cortical attractor neuronal networks." Pharmacology Biochemistry and Behavior 100, no. 4 (2012): 736-751. |
|
Joseph, Jamie, Colin Depp, Pei-an B. Shih, Kristen S. Cadenhead, and Geert Schmid-Schönbein. "Modified Mediterranean diet for enrichment of short chain fatty acids: potential adjunctive therapeutic to target immune and metabolic dysfunction in schizophrenia?." Frontiers in Neuroscience 11 (2017): 155. |
|
Kim, Jungjin, Eric MacMaster, and Thomas L. Schwartz. "Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations." Drugs in context 3 (2014). |
|
Upthegrove, Rachel, and Golam M. Khandaker. "Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia." Neuroinflammation and Schizophrenia (2019): 49-66. |
|
Stramecki, Filip, B?a?ej Misiak, and Dorota Frydecka. "Adjuvant anti-inflammatory therapy in schizophrenia–current evidence." (2017). |
|
Chou, Yuan Hwa, Po-Chung Chu, Szu-Wei Wu, Jen-Chin Lee, Yi-Hsuan Lee, I-Wen Sun, Chen-Lin Chang et al. "A systemic review and experts’ consensus for long-acting injectable antipsychotics in bipolar disorder." Clinical Psychopharmacology and Neuroscience 13, no. 2 (2015): 121. |
|